Genetic Testing Helps Spokane Valley Patient Lose Weight
A local resident found success with targeted medication after traditional bariatric surgery failed to manage her weight.
Updated on Oct. 23, 2026 in Weight Loss
In October 2026, Spokane Valley resident Christy Krauss reported a current weight of 169 pounds after beginning a regimen of genetic testing and daily medication in 2022. This approach follows her initial 2015 bariatric surgery, which resulted in a partial weight loss before she began to regain weight.
Why it matters
Genetic testing can reveal specific gene variants that prevent the brain from signaling satiety, providing a targeted alternative for patients who do not achieve long-term success with bariatric surgery alone. This method addresses hunger signaling issues directly, offering hope for individuals with lifelong weight management challenges.
Genetic testing identifies variants blocking satiety signals, allowing doctors to use setmelanotide, also known as Imcivree, to target the impaired MC4R pathway. Megan Vulcan has applied this diagnostic approach to 72 patients at the MultiCare Rockwood Weight Loss and Bariatric Surgery Center.
The players
Christy Krauss
A Spokane Valley resident and former nail salon owner who struggled with weight management for years.
Megan Vulcan
A medical professional at MultiCare Rockwood Weight Loss and Bariatric Surgery Center who oversees a cohort of 72 patients using genetic testing.
MultiCare Rockwood Weight Loss and Bariatric Surgery Center
A specialized clinical facility providing weight management services in the Spokane region.
The details
Krauss, who weighed 316 pounds in 2015, saw an initial drop of 80 pounds post-surgery before weight regain prompted further investigation. She now uses a daily injection of Imcivree to reach her goal weight of 150 pounds.
Timeline
Christy Krauss underwent bariatric surgery in 2015.
Genetic testing and setmelanotide treatment began in 2022.
Krauss reached a weight of 169 pounds by October 2026.
The Big Picture
This approach aligns with current research into the MC4R pathway, shifting the focus of obesity treatment from simple caloric restriction to correcting neurological signaling defects. It marks a departure from purely surgical interventions by integrating precision medicine to address underlying genetic barriers.
Patients who have not seen lasting success with bariatric surgery may find that genetic testing identifies specific, treatable pathways in their hunger signaling. This requires consultation with a specialist who can determine if daily injections like Imcivree are medically appropriate.
The takeaway
Weight management success often relies on identifying the underlying biological reasons for hunger rather than just caloric intake. Patients who face persistent challenges despite traditional interventions may benefit from discussing genetic testing options with their healthcare providers.
Further reading
Learn more about the latest developments in Weight Loss treatments and clinical advancements.
Source note: This article includes information reported by The Spokesman Review.
